KMID : 0366220160510010023
|
|
Korean Journal of Hematology 2016 Volume.51 No. 1 p.23 ~ p.30
|
|
Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
|
|
Karthik Bommannan
Man Updesh Singh Sachdeva Pankaj Malhotra Narender Kumar Prashant Sharma Shano Naseem Jasmina Ahluwalia Reena Das Neelam Varma Gaurav Prakash Alka Khadwal Radhika Srinivasan Subhash Varma
|
|
Abstract
|
|
|
Background: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell neoplasm. In PCL, clonal plasma cells comprise ¡Ã20% of the peripheral blood (PB) leukocytes and/or the absolute clonal PB plasma cell count is ¡Ã2¡¿109/L. Primary PCL (PPCL) originates de novo, whereas, secondary PCL (SPCL) evolves from pre-existing multiple myeloma.
Methods: Clinicohematological features, immunophenotypic profile, and survival of PCL patients were analyzed retrospectively.
Results: Between January 2007 and December 2014, ten PPCL and four SPCL patients were investigated (8 PPCLs and 3 SPCLs had complete clinical data). All were North Indians, sharing common geography and ethnicity. Our cohort showed less frequent renal failure, more frequent hepatomegaly, and non-secretory type disease. In contrast to western literature, flow cytometric immunophenotyping of our cohort revealed altered expression of CD138 (67%), CD56 (33%), and CD20 (0%). With novel therapeutic agents, these PPCL patients had a median overall survival of 15 months.
Conclusion: We highlight that our PPCL patients from North India had distinct clinicohematological and immunophenotypic profiles. The significance of our findings must be tested in a larger patient cohort and must be supported by molecular and cytogenetic investigations to unmask possible significant effects on pathogenesis.
|
|
KEYWORD
|
|
Clinicohematological profile, North India, Plasma cell leukemia, Immunophenotype, Survival
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|